Indeed, IL-33 expression correlated strongly with CD8A and granzyme B as well as genes like BATF3, IRF8, THBD, CLEC9, and XCR1 that are required for tumor antigen cross-presentation functionality of CD103+ dendritic cells (DCs) (Figure 9E and Supplemental Figure 7C). The gene discussed is BATF3; the disease is neoplasm.